Production (Stage)
Chemed Corporation
CHE
$569.57
$8.131.45%
NYSE
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 646.94M | 639.99M | 606.18M | 595.88M | 589.23M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 646.94M | 639.99M | 606.18M | 595.88M | 589.23M |
| Cost of Revenue | 430.53M | 405.88M | 396.19M | 389.75M | 385.13M |
| Gross Profit | 216.41M | 234.12M | 209.99M | 206.13M | 204.11M |
| SG&A Expenses | 105.59M | 104.25M | 101.98M | 102.26M | 110.54M |
| Depreciation & Amortization | 16.02M | 15.83M | 15.70M | 15.71M | 15.81M |
| Other Operating Expenses | 51.00K | -288.00K | 159.00K | 37.00K | 92.00K |
| Total Operating Expenses | 552.19M | 525.67M | 514.02M | 507.76M | 511.56M |
| Operating Income | 94.76M | 114.32M | 92.16M | 88.13M | 77.67M |
| Income Before Tax | 95.67M | 120.12M | 101.03M | 93.83M | 84.49M |
| Income Tax Expenses | 23.92M | 29.80M | 25.25M | 22.94M | 19.47M |
| Earnings from Continuing Operations | 71.76M | 90.32M | 75.78M | 70.89M | 65.02M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 71.76M | 90.32M | 75.78M | 70.89M | 65.02M |
| EBIT | 94.76M | 114.32M | 92.16M | 88.13M | 77.67M |
| EBITDA | 110.78M | 125.86M | 107.85M | 103.84M | 93.48M |
| EPS Basic | 4.91 | 6.08 | 5.04 | 4.70 | 4.30 |
| Normalized Basic EPS | 4.09 | 5.07 | 4.20 | 3.88 | 3.71 |
| EPS Diluted | 4.86 | 6.03 | 5.00 | 4.65 | 4.24 |
| Normalized Diluted EPS | 4.05 | 5.03 | 4.16 | 3.85 | 3.66 |
| Average Basic Shares Outstanding | 14.62M | 14.85M | 15.03M | 15.10M | 15.12M |
| Average Diluted Shares Outstanding | 14.76M | 14.99M | 15.17M | 15.25M | 15.34M |
| Dividend Per Share | 0.50 | 0.50 | 0.50 | 0.40 | 0.40 |
| Payout Ratio | 10.21% | 8.30% | 9.88% | 8.54% | 9.31% |